265 related articles for article (PubMed ID: 34629823)
1. Impact of radiogenomics in esophageal cancer on clinical outcomes: A pilot study.
Brancato V; Garbino N; Mannelli L; Aiello M; Salvatore M; Franzese M; Cavaliere C
World J Gastroenterol; 2021 Sep; 27(36):6110-6127. PubMed ID: 34629823
[TBL] [Abstract][Full Text] [Related]
2. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
3. Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer.
Piazzese C; Foley K; Whybra P; Hurt C; Crosby T; Spezi E
PLoS One; 2019; 14(11):e0225550. PubMed ID: 31756181
[TBL] [Abstract][Full Text] [Related]
4. Cone-beam computed-tomography-based delta-radiomic analysis for investigating prognostic power for esophageal squamous cell cancer patients undergoing concurrent chemoradiotherapy.
Nakamoto T; Yamashita H; Jinnouchi H; Nawa K; Imae T; Takenaka S; Aoki A; Ohta T; Ozaki S; Nozawa Y; Nakagawa K
Phys Med; 2024 Jan; 117():103182. PubMed ID: 38086310
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced CT-based radiomic analysis for determining the response to anti-programmed death-1 therapy in esophageal squamous cell carcinoma patients: A pilot study.
Yang Q; Huang H; Zhang G; Weng N; Ou Z; Sun M; Luo H; Zhou X; Gao Y; Wu X
Thorac Cancer; 2023 Nov; 14(33):3266-3274. PubMed ID: 37743537
[TBL] [Abstract][Full Text] [Related]
6. CT radiomic features for predicting resectability of oesophageal squamous cell carcinoma as given by feature analysis: a case control study.
Ou J; Li R; Zeng R; Wu CQ; Chen Y; Chen TW; Zhang XM; Wu L; Jiang Y; Yang JQ; Cao JM; Tang S; Tang MJ; Hu J
Cancer Imaging; 2019 Oct; 19(1):66. PubMed ID: 31619297
[TBL] [Abstract][Full Text] [Related]
7. Radiogenomics-based cancer prognosis in colorectal cancer.
Badic B; Hatt M; Durand S; Jossic-Corcos CL; Simon B; Visvikis D; Corcos L
Sci Rep; 2019 Jul; 9(1):9743. PubMed ID: 31278324
[TBL] [Abstract][Full Text] [Related]
8. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
[TBL] [Abstract][Full Text] [Related]
9. Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas.
Yoon J; Suh YJ; Han K; Cho H; Lee HJ; Hur J; Choi BW
Thorac Cancer; 2020 Apr; 11(4):993-1004. PubMed ID: 32043309
[TBL] [Abstract][Full Text] [Related]
10. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
Zinn PO; Singh SK; Kotrotsou A; Hassan I; Thomas G; Luedi MM; Elakkad A; Elshafeey N; Idris T; Mosley J; Gumin J; Fuller GN; de Groot JF; Baladandayuthapani V; Sulman EP; Kumar AJ; Sawaya R; Lang FF; Piwnica-Worms D; Colen RR
Clin Cancer Res; 2018 Dec; 24(24):6288-6299. PubMed ID: 30054278
[TBL] [Abstract][Full Text] [Related]
11. Systematic investigation of the clinical significance and prognostic value of the CBXs in esophageal cancer.
Hou J; Yang Y; Gao H; Ouyang T; Liu Q; Ding R; Kan H
Medicine (Baltimore); 2022 Oct; 101(40):e30888. PubMed ID: 36221371
[TBL] [Abstract][Full Text] [Related]
12. CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer.
Huynh E; Coroller TP; Narayan V; Agrawal V; Hou Y; Romano J; Franco I; Mak RH; Aerts HJ
Radiother Oncol; 2016 Aug; 120(2):258-66. PubMed ID: 27296412
[TBL] [Abstract][Full Text] [Related]
13. Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT?
Wang X; Zhao X; Li Q; Xia W; Peng Z; Zhang R; Li Q; Jian J; Wang W; Tang Y; Liu S; Gao X
Eur Radiol; 2019 Nov; 29(11):6049-6058. PubMed ID: 30887209
[TBL] [Abstract][Full Text] [Related]
14. Computed Tomography-Based Radiomic Features Could Potentially Predict Microsatellite Instability Status in Stage II Colorectal Cancer: A Preliminary Study.
Fan S; Li X; Cui X; Zheng L; Ren X; Ma W; Ye Z
Acad Radiol; 2019 Dec; 26(12):1633-1640. PubMed ID: 30929999
[TBL] [Abstract][Full Text] [Related]
15. Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases.
Zeng JH; Xiong DD; Pang YY; Zhang Y; Tang RX; Luo DZ; Chen G
Oncotarget; 2017 May; 8(22):35681-35699. PubMed ID: 28415685
[TBL] [Abstract][Full Text] [Related]
16. Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.
Zhu Y; Mohamed ASR; Lai SY; Yang S; Kanwar A; Wei L; Kamal M; Sengupta S; Elhalawani H; Skinner H; Mackin DS; Shiao J; Messer J; Wong A; Ding Y; Zhang L; Court L; Ji Y; Fuller CD
JCO Clin Cancer Inform; 2019 Feb; 3():1-9. PubMed ID: 30730765
[TBL] [Abstract][Full Text] [Related]
17. Prediction of response after chemoradiation for esophageal cancer using a combination of dosimetry and CT radiomics.
Jin X; Zheng X; Chen D; Jin J; Zhu G; Deng X; Han C; Gong C; Zhou Y; Liu C; Xie C
Eur Radiol; 2019 Nov; 29(11):6080-6088. PubMed ID: 31028447
[TBL] [Abstract][Full Text] [Related]
18. Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT.
Huynh E; Coroller TP; Narayan V; Agrawal V; Romano J; Franco I; Parmar C; Hou Y; Mak RH; Aerts HJ
PLoS One; 2017; 12(1):e0169172. PubMed ID: 28046060
[TBL] [Abstract][Full Text] [Related]
19. Repeatability of CBCT radiomic features and their correlation with CT radiomic features for prostate cancer.
Delgadillo R; Spieler BO; Ford JC; Kwon D; Yang F; Studenski M; Padgett KR; Abramowitz MC; Dal Pra A; Stoyanova R; Pollack A; Dogan N
Med Phys; 2021 May; 48(5):2386-2399. PubMed ID: 33598943
[TBL] [Abstract][Full Text] [Related]
20. The MR radiomic signature can predict preoperative lymph node metastasis in patients with esophageal cancer.
Qu J; Shen C; Qin J; Wang Z; Liu Z; Guo J; Zhang H; Gao P; Bei T; Wang Y; Liu H; Kamel IR; Tian J; Li H
Eur Radiol; 2019 Feb; 29(2):906-914. PubMed ID: 30039220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
